Bulletin
Investor Alert

NeuroBo Pharmaceuticals Inc.

NAS: NRBO

GO
/marketstate/country/us

After Hours

/zigman2/quotes/207284462/composite

$

0.80

Change

+0.0050 +0.63%

Volume

Volume 24,148

Jan 31, 2023, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/207284462/composite

Today's close

$ 0.81

$ 0.79

Change

-0.02 -2.45%

Day low

Day high

$0.77

$0.81

Open
Open: 0.80

52 week low

52 week high

$0.55

$63.85

Open

Market cap

$15.36M

Average volume

3.21M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-15.61

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nrbo

MarketWatch News on NRBO

  1. Gemphire Therapeutics' stock extends slide, plummets 39% premarket after trial halt

    6:24 a.m. Aug. 10, 2018

    - Tomi Kilgore

  2. Gemphire's stock on track to open at record low

    6:24 a.m. Aug. 10, 2018

    - Tomi Kilgore

  3. Gemphire Therapeutics stock tumbles 17% premarket after trial halt

    6:01 a.m. Aug. 10, 2018

    - Tomi Kilgore

  4. Gemphire's stock on track to open at record low

    6:02 a.m. Aug. 10, 2018

    - Tomi Kilgore

  5. Gemphire Therapeutics downgraded to market perform from outperform at Raymond James

    7:11 a.m. Aug. 7, 2018

    - Tomi Kilgore

  6. Gemphire Therapeutics stock price target raised to $26 from $22 at Raymond James

    7:14 a.m. June 29, 2018

    - Tomi Kilgore

  7. Gemphire Therapeutics started at outperform with $22 stock price target

    7:19 a.m. May 16, 2018

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/nrbo

Other News on NRBO

  1. 10-Q: NEUROBO PHARMACEUTICALS, INC.

    6:18 p.m. Nov. 14, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. AMRS and MACK among mid-day gainers

    1:13 p.m. Nov. 9, 2022

    - Seeking Alpha

  3. TKC, AIU and NRBO are among pre market gainers

    8:33 a.m. Nov. 9, 2022

    - Seeking Alpha

  4. TASK and BVS among mid-day movers

    12:42 p.m. Nov. 8, 2022

    - Seeking Alpha

  5. GTHX, NRBO and HUDI are among pre market gainers

    8:23 a.m. Nov. 8, 2022

    - Seeking Alpha

  6. CPRT and LUNG among mid-day movers

    12:55 p.m. Nov. 4, 2022

    - Seeking Alpha

  7. BLUE, TUSK and TRVI among mid-day movers

    12:54 p.m. Sept. 20, 2022

    - Seeking Alpha

  8. UPS, CPRX and VLTA among pre market losers

    7:25 a.m. Sept. 16, 2022

    - Seeking Alpha

  9. CSCW, ADTX and NVOS among mid-day movers

    11:45 a.m. Sept. 15, 2022

    - Seeking Alpha

  10. KERN, RYTM and SLNH among mid-day movers

    12:02 p.m. Sept. 14, 2022

    - Seeking Alpha

  11. Block, Nucor, Altimmune among premarket losers' pack

    7:24 a.m. Sept. 14, 2022

    - Seeking Alpha

  12. MDGL, OTLK and ENTB among pre market gainers

    7:16 a.m. Sept. 13, 2022

    - Seeking Alpha

  13. 10-Q: NEUROBO PHARMACEUTICALS, INC.

    3:27 p.m. Aug. 12, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  14. 10-Q: NEUROBO PHARMACEUTICALS, INC.

    3:38 p.m. May 13, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  15. 10-K: NEUROBO PHARMACEUTICALS, INC.

    4:20 p.m. March 31, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  16. Loading more headlines...
/news/pressrelease/company/us/nrbo

Press Releases on NRBO

  1. Hot Penny Stocks to Know About Right Now? 3 to Watch

    5:00 a.m. Sept. 13, 2022

    - Penny Stocks

  2. NeuroBo Pharmaceuticals Announces Reverse Stock Split

    8:15 a.m. Sept. 12, 2022

    - PR Newswire - PRF

  3. NeuroBo Pharmaceuticals Reports Full Year 2021 Financial Results

    7:00 a.m. April 1, 2022

    - PR Newswire - PRF

  4. EVIO Inc. (EVIO) Expands Footprint to Los Angeles

    11:18 a.m. June 4, 2018

    - NetworkNewsWire

Rates »

Link to MarketWatch's Slice.